SAN DIEGO, Calif. (January 11, 2016)—ResMed today announced it has entered into a definitive agreement to acquire Inova Labs Inc., a privately held medical device company specializing in the development and commercialization of innovative oxygen therapy products. Oxygen therapy is the largest non-drug delivery medical device segment for the treatment of COPD.
ResMed
One House Call Has Big Aging-In-Place Payoff
When it comes to helping seniors age in their own home, an in-home assessment from a physician or nurse practitioner goes a long way. (Tim Mullaney/Home Health Care News)
SAN DIEGO (November 5, 2015)—CareFusion, a BD company (NYSE: BDX), today announced its AirLife business line has signed an exclusive agreement with ResMed (NYSE: RMD) to distribute innovative nasal high flow interface products from the company.
A ResMed retrospective descriptive study of myAir usage data demonstrated a connection between continuous positive airway pressure (CPAP) device usage, digital health applications and high compliance. According to the study of 2,343 de-identified patient records, researchers found 83.9 percent of new CPAP users who received standard care and used the ResMed myAir application achieved Medicare adherence in the first 90 days of their treatment.
ResMed has achieved significant growth milestones in healthcare informatics, with key new partner and customer integrations.
